ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 21 May 2018
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
87208628 filed on 19th Oct 2016
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
NIVOCUS
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 87208628
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st May 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 21st May 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| 17th Oct 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 22nd Aug 2017 | PUBLISHED FOR OPPOSITION |
| 22nd Aug 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Aug 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 13th Jul 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 12th Jul 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 11th Jul 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 11th Jul 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |